183 related articles for article (PubMed ID: 15598877)
1. Valproate-induced alterations in human theca cell gene expression: clues to the association between valproate use and metabolic side effects.
Wood JR; Nelson-Degrave VL; Jansen E; McAllister JM; Mosselman S; Strauss JF
Physiol Genomics; 2005 Feb; 20(3):233-43. PubMed ID: 15598877
[TBL] [Abstract][Full Text] [Related]
2. The molecular signature of polycystic ovary syndrome (PCOS) theca cells defined by gene expression profiling.
Wood JR; Ho CK; Nelson-Degrave VL; McAllister JM; Strauss JF
J Reprod Immunol; 2004 Aug; 63(1):51-60. PubMed ID: 15284005
[TBL] [Abstract][Full Text] [Related]
3. Valproate potentiates androgen biosynthesis in human ovarian theca cells.
Nelson-DeGrave VL; Wickenheisser JK; Cockrell JE; Wood JR; Legro RS; Strauss JF; McAllister JM
Endocrinology; 2004 Feb; 145(2):799-808. PubMed ID: 14576182
[TBL] [Abstract][Full Text] [Related]
4. The anti-epileptic drug valproic acid (VPA) inhibits steroidogenesis in bovine theca and granulosa cells in vitro.
Glister C; Satchell L; Michael AE; Bicknell AB; Knight PG
PLoS One; 2012; 7(11):e49553. PubMed ID: 23152920
[TBL] [Abstract][Full Text] [Related]
5. Comparison of reproductive effects of levetiracetam and valproate studied in prepubertal porcine ovarian follicular cells.
Taubøll E; Gregoraszczuk EL; Tworzydø A; Wójtowicz AK; Ropstad E
Epilepsia; 2006 Sep; 47(9):1580-3. PubMed ID: 16981877
[TBL] [Abstract][Full Text] [Related]
6. Valproic acid induces apoptosis in chronic lymphocytic leukemia cells through activation of the death receptor pathway and potentiates TRAIL response.
Lagneaux L; Gillet N; Stamatopoulos B; Delforge A; Dejeneffe M; Massy M; Meuleman N; Kentos A; Martiat P; Willems L; Bron D
Exp Hematol; 2007 Oct; 35(10):1527-37. PubMed ID: 17697742
[TBL] [Abstract][Full Text] [Related]
7. A meta-analysis of polycystic ovary syndrome in women taking valproate for epilepsy.
Hu X; Wang J; Dong W; Fang Q; Hu L; Liu C
Epilepsy Res; 2011 Nov; 97(1-2):73-82. PubMed ID: 21820873
[TBL] [Abstract][Full Text] [Related]
8. The molecular phenotype of polycystic ovary syndrome (PCOS) theca cells and new candidate PCOS genes defined by microarray analysis.
Wood JR; Nelson VL; Ho C; Jansen E; Wang CY; Urbanek M; McAllister JM; Mosselman S; Strauss JF
J Biol Chem; 2003 Jul; 278(29):26380-90. PubMed ID: 12734205
[TBL] [Abstract][Full Text] [Related]
9. In vivo anti-myeloma activity and modulation of gene expression profile induced by valproic acid, a histone deacetylase inhibitor.
Neri P; Tagliaferri P; Di Martino MT; Calimeri T; Amodio N; Bulotta A; Ventura M; Eramo PO; Viscomi C; Arbitrio M; Rossi M; Caraglia M; Munshi NC; Anderson KC; Tassone P
Br J Haematol; 2008 Nov; 143(4):520-31. PubMed ID: 18986388
[TBL] [Abstract][Full Text] [Related]
10. Molecular profiling of polycystic ovaries for markers of cell invasion and matrix turnover.
Oksjoki S; Söderström M; Inki P; Vuorio E; Anttila L
Fertil Steril; 2005 Apr; 83(4):937-44. PubMed ID: 15820804
[TBL] [Abstract][Full Text] [Related]
11. Increased transcription and increased messenger ribonucleic acid (mRNA) stability contribute to increased GATA6 mRNA abundance in polycystic ovary syndrome theca cells.
Ho CK; Wood JR; Stewart DR; Ewens K; Ankener W; Wickenheisser J; Nelson-Degrave V; Zhang Z; Legro RS; Dunaif A; McAllister JM; Spielman R; Strauss JF
J Clin Endocrinol Metab; 2005 Dec; 90(12):6596-602. PubMed ID: 16159937
[TBL] [Abstract][Full Text] [Related]
12. [Effects of sodium valproate on proliferation and apoptosis of human myelodysplastic syndromes cell line MUTZ-1].
Chen BA; Zhao HH; Gao C; Shao ZY; Xia GH; Dohner K
Ai Zheng; 2007 Dec; 26(12):1323-9. PubMed ID: 18076794
[TBL] [Abstract][Full Text] [Related]
13. The biochemical basis for increased testosterone production in theca cells propagated from patients with polycystic ovary syndrome.
Nelson VL; Qin KN; Rosenfield RL; Wood JR; Penning TM; Legro RS; Strauss JF; McAllister JM
J Clin Endocrinol Metab; 2001 Dec; 86(12):5925-33. PubMed ID: 11739466
[TBL] [Abstract][Full Text] [Related]
14. Increased cytochrome P450 17alpha-hydroxylase promoter function in theca cells isolated from patients with polycystic ovary syndrome involves nuclear factor-1.
Wickenheisser JK; Nelson-DeGrave VL; Quinn PG; McAllister JM
Mol Endocrinol; 2004 Mar; 18(3):588-605. PubMed ID: 14684846
[TBL] [Abstract][Full Text] [Related]
15. Valproic acid and CEBPalpha-mediated regulation of adipokine gene expression in hypothalamic neurons and 3T3-L1 adipocytes.
Brown R; Imran SA; Ur E; Wilkinson M
Neuroendocrinology; 2008; 88(1):25-34. PubMed ID: 18212493
[TBL] [Abstract][Full Text] [Related]
16. Valproic acid fails to induce polycystic ovary syndrome in female rats.
Lagace DC; Nachtigal MW
Prog Neuropsychopharmacol Biol Psychiatry; 2003 Jun; 27(4):587-94. PubMed ID: 12787843
[TBL] [Abstract][Full Text] [Related]
17. Multiple Molecular pathways explain the anti-proliferative effect of valproic acid on prostate cancer cells in vitro and in vivo.
Shabbeer S; Kortenhorst MS; Kachhap S; Galloway N; Rodriguez R; Carducci MA
Prostate; 2007 Jul; 67(10):1099-110. PubMed ID: 17477369
[TBL] [Abstract][Full Text] [Related]
18. Selective alterations in insulin receptor substrates-1, -2 and -4 in theca but not granulosa cells from polycystic ovaries.
Yen HW; Jakimiuk AJ; Munir I; Magoffin DA
Mol Hum Reprod; 2004 Jul; 10(7):473-9. PubMed ID: 15155816
[TBL] [Abstract][Full Text] [Related]
19. Reduced expression of nuclear-encoded genes involved in mitochondrial oxidative metabolism in skeletal muscle of insulin-resistant women with polycystic ovary syndrome.
Skov V; Glintborg D; Knudsen S; Jensen T; Kruse TA; Tan Q; Brusgaard K; Beck-Nielsen H; Højlund K
Diabetes; 2007 Sep; 56(9):2349-55. PubMed ID: 17563058
[TBL] [Abstract][Full Text] [Related]
20. Augmented androgen production is a stable steroidogenic phenotype of propagated theca cells from polycystic ovaries.
Nelson VL; Legro RS; Strauss JF; McAllister JM
Mol Endocrinol; 1999 Jun; 13(6):946-57. PubMed ID: 10379893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
